Open competition
Open procedure: the contract was advertised and any supplier could submit a bid.
Key facts
- Buyer
- NHS England · Body governed by public law
- Suppliers
- Bio Products Laboratory Ltd, CSL Behring UK Ltd, Grifols UK Ltd., LFB, Octapharma Limited, Takeda UK Ltd
- Value
- £905,187,090
- Procedure
- Open procedure (above threshold)
- Sector
- Medical equipment & pharmaceuticals · Immunoglobulins (CPV 33651520)
- Region
- North West
- Official notice
- View on Contracts Finder
- Timeline
-
- Contract date19 Dec 2024
- Published20 Jan 2025Published 32 days after the contract date
Description
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.
About the suppliers
Bio Products Laboratory Ltd: every public contract they have won, plus their Companies House record (company 07343036).
CSL Behring UK Ltd: every public contract they have won, plus their Companies House record (company 01622483).
Grifols UK Ltd.: every public contract they have won.
LFB: every public contract they have won, plus their Companies House record (company 01118740).
Octapharma Limited: every public contract they have won.
Takeda UK Ltd: every public contract they have won, plus their Companies House record (company 03362860).